HemoPill monitor: First case of long-term (28 day) use successful

First application of the HemoPill® monitor capsule for 28 days in patient with fundus variceal bleeding technically successful and clinically straightforward

Key findings
• Long term out of hospital monitoring (28 days) of potential re-bleeding after endoscopic treatment in patient with fundus variceal bleeding
• 10 events were detected by the system throughout the monitoring period, with a combined estimated time of 90 minutes, showing the system’s ability to detect even small haemorrhages
• Mucosal haemorrhage due to penetrating cyanoacrylate was postulated as a possible cause of the self-limiting bleeding
• Patient was able to handle the system easily and without complications

Case details
• Capsule was fixed with an OTSC^® Clip in the distal corpus as part of an EGD (duration 8 min)
• Control endoscopies were performed on day 15 and day 28
• Patient had daily blood pressure measurements and weekly Hb checks
• Clip and capsule were removed on day 28 with the remOVE System without complications

Brand M, Meining A. A new capsule for long term monitoring in suspected upper GI-bleeding – first in human use of the HemoPill monitor™. ESGE Days 2024 (25-27 April), Berlin, Germany.

For further clinical and product information, please follow our website links on the HemoPill®.

If you would like personal advice on our products, please do not hesitate to contact your local representative or contact us directly.

Yours sincerely,
the team from the Ovesco Scientific Information Service